Works matching IS 08853185 AND DT 1993 AND VI 8 AND IP S1

Results: 9

The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in parkinson's disease.

Published in:

Movement Disorders, 1993, v. 8, n. S1, p. S8, doi. 10.1002/mds.870080504

By:

Youdim, M. B. H.;
Riederer, P.

Publication type:

Article

Symptomatic effect of selegiline in de novo parkinsonian patients.

Published in:

Movement Disorders, 1993, v. 8, n. S1, p. S36, doi. 10.1002/mds.870080508

By:

Allain, H.;
Pollak, P.;
Neukirch, H. C.

Publication type:

Article

A rationale for monoamine oxidase inhibition as neuroprotective therapy for parkinson's disease.

Published in:

Movement Disorders, 1993, v. 8, n. S1, p. S1, doi. 10.1002/mds.870080503

By:

Olanow, C. W.

Publication type:

Article

Nigral degeneration in parkinson's disease.

Published in:

Movement Disorders, 1993, v. 8, n. S1, p. S31, doi. 10.1002/mds.870080507

By:

Rinne, J. O.

Publication type:

Article

Preface.

Published in:

Movement Disorders, 1993, v. 8, n. S1, p. v, doi. 10.1002/mds.870080502

By:

Riederer, P.;
Rinne, U. K.

Publication type:

Article

Selegiline can mediate neuronal rescue rather than neuronal protection.

Published in:

Movement Disorders, 1993, v. 8, n. S1, p. S20, doi. 10.1002/mds.870080506

By:

Tatton, W. G.

Publication type:

Article

Masthead.

Published in:: Movement Disorders, 1993, v. 8, n. S1, p. fmi, doi. 10.1002/mds.870080501
Publication type:: Article

Neurotoxins and monoamine oxidase inhibition: New aspects.

Published in:

Movement Disorders, 1993, v. 8, n. S1, p. S14, doi. 10.1002/mds.870080505

By:

Finnegan, K. T.

Publication type:

Article

Selegiline in de novo parkinsonian patients: The finnish study.

Published in:

Movement Disorders, 1993, v. 8, n. S1, p. S41, doi. 10.1002/mds.870080509

By:

Myllylä, V. V.;
Sotaniemi, K. A.;
Vuorinen, J. A.;
Heinonen, E. H.

Publication type:

Article